|
- Molecular detection of XO - Turner syndrome
- Carlos Alberto Longui1,2, Mylene Neves Rocha2, Liana Carla Albuquerque Peres Martinho1,
- Gustavo Gir Gomes2, Ricardo Eustachio de Miranda2, Thomas Alves de Souza Lima2, Mônica Barbosa Melo2 and Osmar Monte1,2
- 1Pediatric Department, Pediatric Endocrinology Unit, Santa Casa deSão Paulo, School of Medicine,
- São Paulo SP, Brazil
- 2Physiology Department, Santa Casa de São Paulo, School of Medicine, São Paulo SP, Brazil
- Corresponding author: C.A. Longui
- E-mail: fisiolab@santacasasp.org.br
- Genet. Mol. Res. 1 (3): 266-270 (2002)
- Received April 4, 2002
- Published September 23, 2002
ABSTRACT. Turner syndrome is caused by haploinsufficiency of the short arm of X-chromosome, and is usually diagnosed by karyotyping. This procedure is time-consuming, expensive and unfeasible for population screening. We propose molecular detection of 45XO Turner patients based on the ability of HpaII, a methylation sensitive endonuclease, to induce the cleavage of non-methylated DNA in the active X-allele. Genomic DNA was obtained from 22 patients with Turner syndrome confirmed by karyotype (45XO, N = 18; 45XO/46XX, N = 4). After digestion, DNA was amplified with primers directed to exon 1 of the androgen receptor (AR) gene and to the GAPDH control gene. Normal control females or mosaic patients, with a second methylated X-chromosome, escaped from HpaII digestion and produced a band corresponding to AR gene amplification. 45XO patients have just one active non-methylated X-chromosome, completely digested by HpaII, thus preventing the amplification of the AR gene. Three of the 45XO cases gave amplified bands, suggesting low-frequency mosaicisms that are not detected by karyotyping. Compared to classical karyotype studies for the detection of 45XO Turner patients, this new molecular method is simpler, faster and less expensive.
Key words: Molecular diagnosis, Turner syndrome, X-Chromosome methylation
|